Form D · Biotechnology
InCellDx, Inc.
Hayward, CA · CIK 0001494461
Offering snapshot reported Jul 23, 2024 · SEC filing
- Reported sold
- $500K Offering amount: $13.5M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Jul 16, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 23, 2024 | Initial | $500,000 | No comparison | 1 | SEC filing |
| May 14, 2012 | Initial | $5,999,998 | No comparison | 1 | SEC filing |
| Jun 17, 2010 | Initial | $3,000,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-519545
Source: Form D, filed Jul 23, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Brian Recroft Brothen | Executive |
| Marc D Grodman | Director |
| Lowell Gruman | Executive |
| Eric Hass | Executive |
| Linda Law | Director |
| Bruce Patterson | Executive |
| Carol Penfold Patterson | Director, Executive |
| Thaddeus Taube | Director |
| Charles T Todd | Director |
| Chris Lawrence Wheeler | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
30920 Huntwood Avenue
Hayward, CA, 94544
Hayward, CA, 94544